• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter to the editor: Comments on 'A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation'.

作者信息

Diekstra Meta H M, Malmberg Ruben, Sleijfer Stefan, van Leeuwen Roelof W F

机构信息

Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands.

Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

出版信息

Eur J Cancer. 2020 Oct;138:54-56. doi: 10.1016/j.ejca.2020.07.014. Epub 2020 Aug 24.

DOI:10.1016/j.ejca.2020.07.014
PMID:32854077
Abstract
摘要

相似文献

1
Letter to the editor: Comments on 'A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation'.致编辑的信：关于“基于建模与模拟评估的癌症患者帕博利珠单抗六周给药方案”的评论
Eur J Cancer. 2020 Oct;138:54-56. doi: 10.1016/j.ejca.2020.07.014. Epub 2020 Aug 24.
2
A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation.基于建模和模拟评估的癌症患者每六周一次的帕博利珠单抗给药方案。
Eur J Cancer. 2020 May;131:68-75. doi: 10.1016/j.ejca.2020.02.016. Epub 2020 Apr 15.
3
Letter to the editor: Model-based simulation to support the extended dosing regimens of atezolizumab.致编辑的信：基于模型的模拟以支持阿替利珠单抗的延长给药方案
Eur J Clin Pharmacol. 2021 Jul;77(7):1065-1066. doi: 10.1007/s00228-020-03054-0. Epub 2021 Jan 7.
4
Evaluation of dosing strategy for pembrolizumab for oncology indications.评估派姆单抗在肿瘤适应证中的给药策略。
J Immunother Cancer. 2017 May 16;5:43. doi: 10.1186/s40425-017-0242-5. eCollection 2017.
5
Letter to the editor: Comments on 'A case of pembrolizumab-induced autoimmune haemolytic anaemia with polymyalgia rheumatica'.致编辑的信：关于“一例帕博利珠单抗诱导的自身免疫性溶血性贫血伴风湿性多肌痛”的评论
Eur J Cancer. 2019 Apr;111:59-60. doi: 10.1016/j.ejca.2018.11.034. Epub 2019 Feb 28.
6
Letter to the editor: radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers.给编辑的信：预测晚期罕见癌症患者对 pembrolizumab 反应的放射组学分析。
J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2021-003044.
7
Weight-based dosing vs fixed dosing of pembrolizumab: an economic analysis.帕博利珠单抗基于体重的给药方案与固定剂量给药方案的经济学分析
Clin Adv Hematol Oncol. 2018 Aug;16(8):549-551.
8
Corrigendum to "A six-weekly (Q6W) dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation" [Eur J Canc 131 (2020) 68-75].《基于建模与模拟评估的帕博利珠单抗用于癌症患者的每六周（Q6W）给药方案》勘误 [《欧洲癌症杂志》131卷（2020年）68 - 75页]
Eur J Cancer. 2021 Feb;144:400. doi: 10.1016/j.ejca.2020.12.006. Epub 2021 Jan 4.
9
Authors' reply to letters to the editor "model-based simulation to support the extended dosing regimens of atezolizumab".作者对致编辑的信《基于模型的模拟以支持阿替利珠单抗的延长给药方案》的回复
Eur J Clin Pharmacol. 2021 Jul;77(7):1067-1068. doi: 10.1007/s00228-020-03055-z. Epub 2020 Nov 25.
10
Pembrolizumab: Role of Modeling and Simulation in Bringing a Novel Immunotherapy to Patients With Melanoma.帕博利珠单抗：建模与模拟在为黑色素瘤患者引入新型免疫疗法中的作用。
CPT Pharmacometrics Syst Pharmacol. 2017 Jan;6(1):5-7. doi: 10.1002/psp4.12131. Epub 2016 Nov 5.

引用本文的文献

1
Combatting the rising costs of cancer drugs; interventions from a university hospital's perspective.应对抗癌药物成本上升；从大学医院视角出发的干预措施
Front Pharmacol. 2023 Aug 28;14:1264951. doi: 10.3389/fphar.2023.1264951. eCollection 2023.